Vascular protection to increase the safety of tissue plasminogen activator for stroke

Tauheed Ishrat, Sahar Soliman, Weihua Guan, Mihaela Saler, Susan C. Fagan

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Thrombolytic therapy with tissue plasminogen activator (tPA) remains the most effective treatment for acute ischemic stroke, but can cause vascular damage leading to edema formation and hemorrhagic transformation (HT). In this review, we discuss how tPA contributes to the pathogenesis of vascular damage and highlight evidence to support combination therapy of tPA with pharmacological agents that are vascular protective. There is an unmet need to develop therapeutic interventions which target the underlying mechanisms of vascular damage after acute ischemic stroke in order to prevent HT and improve the safety and impact of tPA.

Original languageEnglish (US)
Pages (from-to)3677-3684
Number of pages8
JournalCurrent Pharmaceutical Design
Volume18
Issue number25
DOIs
Publication statusPublished - Oct 22 2012

    Fingerprint

Keywords

  • Blood-brain barrier
  • Hemorrhagic transformation (HT)
  • Ischemic stroke
  • Matrix metalloproteinases (MMPs)
  • Thrombolysis
  • Tissue plasminogen activator (tPA)
  • Vascular protection

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this